Because of the wide distribution of FAP in numerous cancer types (e.g., sarcoma, prostate cancer, breast cancer, lung cancer, pancreatic cancer, head and neck cancer, colorectal cancer) the question arises whether FAP can be a novel therapeutic target in cancer (Fig. 1). This evidence concerns the gene FAP and Familial prostate cancer.